Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.

Takada K, Tanioka M, Zamami Y, Toyooka S, Maeda Y

Open source

DOI
10.1007/s10147-026-03202-z
Published
2026 Oct 3
Container
International journal of clinical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-03202-z,
  title = {Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.},
  author = {Takada K and Tanioka M and Zamami Y and Toyooka S and Maeda Y},
  year = {2026},
  journal = {International journal of clinical oncology},
  doi = {10.1007/s10147-026-03202-z},
  url = {https://doi.org/10.1007/s10147-026-03202-z}
}

RIS

TY  - JOUR
TI  - Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.
AU  - Takada K
AU  - Tanioka M
AU  - Zamami Y
AU  - Toyooka S
AU  - Maeda Y
PY  - 2026
JO  - International journal of clinical oncology
DO  - 10.1007/s10147-026-03202-z
UR  - https://doi.org/10.1007/s10147-026-03202-z
ER  - 

APA

K, T., M, T., Y, Z., S, T., & Y, M. (2026). Serum albumin is associated with immune-related hypothyroidism and treatment continuity in non-small cell lung cancer.. International journal of clinical oncology. https://doi.org/10.1007/s10147-026-03202-z

Source records